Cargando…
Targeting claudin‐4 enhances chemosensitivity in breast cancer
Triple negative breast cancer (TNBC) is characterized by highly aggressive phenotype, limited treatment options and a poor prognosis. In the present study, we examined the therapeutic effect of anti–claudin (CLDN)‐4 extracellular domain antibody, 4D3, on TNBC. When the expression of CLDN4 and CLDN1...
Autores principales: | Luo, Yi, Kishi, Shingo, Sasaki, Takamitsu, Ohmori, Hitoshi, Fujiwara‐Tani, Rina, Mori, Shiori, Goto, Kei, Nishiguchi, Yukiko, Mori, Takuya, Kawahara, Isao, Kondoh, Masuo, Kuniyasu, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226188/ https://www.ncbi.nlm.nih.gov/pubmed/32086991 http://dx.doi.org/10.1111/cas.14361 |
Ejemplares similares
-
Targeting claudin‐4 enhances chemosensitivity of pancreatic ductal carcinomas
por: Sasaki, Takamitsu, et al.
Publicado: (2019) -
Anti-claudin-4 extracellular domain antibody enhances the antitumoral effects of chemotherapeutic and antibody drugs in colorectal cancer
por: Fujiwara-Tani, Rina, et al.
Publicado: (2018) -
Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer
por: Nishiguchi, Yukiko, et al.
Publicado: (2019) -
Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas
por: Nakashima, Chie, et al.
Publicado: (2020) -
Role of Nuclear Claudin-4 in Renal Cell Carcinoma
por: Owari, Takuya, et al.
Publicado: (2020)